Cardiovascular safety of linagliptin in type 2 diabetes: a comprehensive patient-level pooled analysis of prospectively adjudicated cardiovascular events
Crossref DOI link: https://doi.org/10.1186/s12933-015-0215-2
Published Online: 2015-05-21
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rosenstock, Julio
Marx, Nikolaus
Neubacher, Dietmar
Seck, Thomas
Patel, Sanjay
Woerle, Hans-Juergen
Johansen, Odd Erik
License valid from 2015-05-21
Article History
Received: 17 March 2015
Accepted: 27 April 2015
First Online: 21 May 2015